Trial intelligence / Profile preview

Prograf to Advagraf Conversion in Kidney-Pancreas Transplant Recipients

NCT01797341Phase 3Completed

Sponsor
University Health Network
Start
Jun 2013
Primary completion
Feb 2014
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tacrolimus in kidney transplant rejection, pancreas transplant rejection, sponsored by University Health Network. Started Jun 2013; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejectionpancreas transplant rejection

Beyond the preview

Go deeper on NCT01797341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01797341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call